IQVIA Holdings Inc. (IQV)

NYQ – Real vaqt narxi. Valyuta: USD

191.14

+4.71 (2.53%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

191.56

+0.42 (0.22%)

Bozordan keyin: Jun 26, 2026, 7:10 PM EDT

17.06.2026

Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.

15.06.2026

Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity

IQVIA Holdings gains from its vast healthcare data, AI-driven analytics & global IT infrastructure, supporting expansion and solid growth.

15.06.2026

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

04.06.2026

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

04.06.2026

IQVIA Announces Pricing of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €950,000,000 in aggregate principal amount of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer's existing indebtedness and to pay fees and expenses related to the Notes offering. The Notes will bear interest at a rate of 4.625% per annum a.

03.06.2026

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

03.06.2026

IQVIA Announces Offering of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 through an offering of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer's existing indebtedness and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other custo.

Videolar

No Data

There is no data to display

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, is advancing its strategic collaboration with Kexing Biopharm to support a global, multi-product biosimilar development and commercialization program. Kexing Biopharm (Stock Code: 688136.SH) is an innovative biopharmaceutical enterprise mainly engaged in the R&D, production an.

07.05.2026

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that its board of directors authorized the repurchase of an additional $2 billion of IQVIA's common stock under IQVIA's existing equity repurchase program (the “Repurchase Program”), bringing the total remaining authorization to $3.2 billion.

IQVIA Holdings Inc. (IQV)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IQVIA Holdings Inc. (IQV)

Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA Announces Pricing of Senior Notes

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Announces Offering of Senior Notes

Videolar

No Data

Press-relizlar

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA Announces Pricing of Senior Notes

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Announces Offering of Senior Notes

Videolar

No Data

Press-relizlar

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

Search stocks

IQVIA Holdings Inc. (IQV)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IQVIA Holdings Inc. (IQV)

Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA Announces Pricing of Senior Notes

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Announces Offering of Senior Notes

Videolar

No Data

Press-relizlar

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA Announces Pricing of Senior Notes

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Announces Offering of Senior Notes

Videolar

No Data

Press-relizlar

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization